Ocean Biomedical (NASDAQ: OCEA) Research Summary | AlphaStreet
Ocean Biomedical, Inc. (NASDAQ: OCEA) is a preclinical biotech firm targeted on shifting new therapeutic candidates effectively from the laboratory ...
Ocean Biomedical, Inc. (NASDAQ: OCEA) is a preclinical biotech firm targeted on shifting new therapeutic candidates effectively from the laboratory ...
Trxade Well being, Inc. (NASDAQ: MEDS) is a drug procurement and supply platform with a mission to revolutionize the healthcare ...
Cardinal Well being (NYSE: CAH), a number one prescription drugs distributor, on Wednesday reported a rise in revenues and adjusted ...
Division retailer chain BJ’s Wholesale Membership Holdings, Inc. (NYSE: BJ) has introduced outcomes for the primary quarter of 2024, reporting a ...
Trxade Well being, Inc. (NASDAQ: MEDS) is a drug procurement and supply platform that digitalizes the retail pharmacy expertise. The ...
Comerica Integrated (NYSE: CMA) reported a lower in web curiosity revenue and adjusted earnings for the primary quarter of 2024. ...
FactSet Analysis Methods Inc. (NYSE: FDS), a number one supplier of information analytics providers, introduced monetary outcomes for the second ...
Trxade Well being, Inc. (NASDAQ: MEDS) operates as an built-in drug procurement and supply platform, centered on digitalizing the retail ...
Healthcare service supplier Centene Company (NYSE: CNC) on Tuesday introduced fourth-quarter 2023 outcomes, reporting a rise in revenues and a ...
Monetary providers firm Residents Monetary Group, Inc. (NYSE: CFG) on Wednesday reported earnings for the fourth quarter of 2023. The ...
Copyright © 2023 expertrefi.org.
expertrefi.org is not responsible for the content of external sites.
Copyright © 2023 expertrefi.org.
expertrefi.org is not responsible for the content of external sites.